Form D Explorer

Inspect source fieldsReport a record issue

Form D — Bonum Therapeutics, Inc.

0001898714-26-000001 · filed Apr 17, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$32,301,381
Reported amount sold
$26,907,396
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Bonum Therapeutics, Inc.
CIK
1898714
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
1150 EASTLAKE AVENUE E
SEATTLE, Washington 98109
Phone
206-888-8485

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗